Cargando…
Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit
BACKGROUND: Children with Idiopathic Short Stature do not attain a normal adult height. The improvement of adult height with treatment with recombinant human growth hormone (rhGH), at doses of 0.16 to 0.28 mg/kg/week is modest, usually less that 4 cm, and they remain short as adults. The benefit obt...
Autores principales: | Sotos, Juan F, Tokar, Naomi J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114101/ https://www.ncbi.nlm.nih.gov/pubmed/25075207 http://dx.doi.org/10.1186/1687-9856-2014-15 |
Ejemplares similares
-
Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
por: Chae, Hyun Wook, et al.
Publicado: (2022) -
Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency
por: Kim, Seul Ah, et al.
Publicado: (2014) -
Association between uric acid and height during growth hormone therapy in children with idiopathic short stature
por: Yoon, Jong Seo, et al.
Publicado: (2022) -
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height
por: Ariza-Jimenez, Ana-Belen, et al.
Publicado: (2021) -
Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency
por: Alzahrani, Ali K, et al.
Publicado: (2020)